Published

Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: JAMA network open
Date: 2025-07-01
Source: PubMed
DOI: 10.1001/jamanetworkopen.2025.24119
PubMed: 40736734

Authors

Hieronymus F López E Werin Sjögren H Lundberg J

Watch author

Derived topics and classifications

psilocybin Depression Receptor Pharmacology Clinical Trial Meta-Analysis Systematic Review Review Article Treatment-Resistant Depression Meta-Analysis

Citation graph

0 referenced DOIs found in stored source metadata. 6 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEW2026-06-24 Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression2026-05-15 Psilocybin in the Treatment of Cocaine Use Disorder2026-05-07 Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression2026-05-01 A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression2026-04-06 Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.2025-07-01

Related papers

Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of DepressionZenodo (CERN European Organization for Nuclear Research) · 2026-07-17 A Systematic Review of EEG Predictors and Correlates of Psilocybin’s Treatment in DepressionUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2026-07-27 Psychedelic Therapies in the Management of Post-Traumatic Stress DisorderJournal of Education Health and Sport · 2026-07-16 Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overviewJournal of Psychedelic Studies · 2026-07-13 Psychedelic Therapy for DepressionUnknown journal · 2026-08-11 Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06 Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.Molecular psychiatry · 2026-07-28